BISTTRY11:05Live
Rta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş.RTALB
Main MarketChemicals, Petroleum, Rubber and Plastics
1.98−0.03 (−1.49%)
- Volume
- TRY 47.7M
- Day range
- 1.94 – 2.15
- Previous close
- 2.01
- Market cap
- TRY 990M
RTALB Ratio Analysis: P/E, P/B, EV/EBITDA
35 key ratios for Rta Laboratuvarları Biyolojik Ürünler İlaç ve Makine Sanayi Ticaret A.Ş. (RTALB) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.
Ratio Analysis
| P/E | 20.93 |
| P/B | 0.35 |
| EV/EBITDA | −221.72 |
| Dividend yield | — |
| Beta | — |
| Earnings per share | 0.1 TL |
| Book value per share | 5.8 TL |
| EBITDA | −11.8M TL |
| Net profit | −566.7M TL |
| Operating profit | −22.8M TL |
| Operating profit before finance costs | −624M TL |
| Net working capital | 227.6M TL |
| Gross margin | 22.17% |
| Operating margin | −13.22% |
| Net margin | −329.15% |
| Return on assets | 1.69% |
| Return on equity | 1.85% |
| Current ratio | 4.80 |
| Quick ratio | 4.15 |
| Cash ratio | — |
| Leverage ratio | 11.00 |
| Debt to equity | 0.12 |
| Debt to assets | 0.11 |
| Fixed assets to equity | 1.03 |
| Short-term debt share | 0.00 |
| Interest coverage | — |
| Receivables turnover | 0.30 |
| Days sales outstanding | 1,217 |
| Inventory turnover | 3.43 |
| Days inventory outstanding | 106 |
| Payables turnover | 3.83 |
| Days payables outstanding | 95 |
| Working capital turnover | 0.76 |
| Equity turnover | 0.06 |
| Asset turnover | 0.05 |
Frequently asked questions
What is the P/E ratio of RTALB?
RTALB has a P/E ratio of 20.93, a P/B ratio of 0.35 and an EV/EBITDA of −221.72.
When are the ratios updated?
Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.